Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
yes to both
IDTA very significant news,
International Substance Detection Firm IDenta Enters Partnership With Jant Pharmacal - Co-Branded Drug Detection Products To Be Named Accutest-IDenta
JERUSALEM, Israel, February 11 - IDenta Corp. (OTC Pink Sheets: IDTA - News) announced today that it has agreed to enter a strategic partnership with Jant Pharmacal, www.accutest.net, based in Encino California. The agreement is for Jant to have the exclusive distribution of IDenta's STINGER line of professional drug identification products in the United States. The products will bear the new co-brand name of Accutest-IDenta.
"This agreement once again confirms the representations our company has put forth now for many years," stated Yaacov Shoham, CEO of IDenta Corp. "IDenta has a superior drug detection product line which performs with 100% accuracy. Jant Pharmacal is an outstanding company to be associated with, and IDenta is committed to developing a partnership which we believe will help further our reputations as industry leaders. I want to personally thank Mr. Eyal Golan, Manager of Business Development for Jant Pharmacal for his expertise in negotiating this agreement, and for the long hours he has put in to get this far in such a very short time. We expect that the sales of Accutest-IDenta to have an immediate impact on our revenues."
The relationship with Jant Pharmacal has been in development for only a few months with IDenta's products being successfully demonstrated by the company at several major events last months including:
1. 42nd California Narcotic Officers' Association Expo
2. The National Safety Council's Congress & Expo in San Diego
3. COPSWest - Americas Premier Law Enforcement Expo
The events resulted in a very large numbers of leads for IDenta products all over the country, which helped initiate the resulting strategic partnership between the two companies.
Jant Pharmacal currently has over 50 representatives in the United States who are selling the company's drug and explosive detection products to law enforcement and security agencies on the federal, state and local level. A very detailed strategic plan for the introducing the Accutest-IDenta product line to the company's representatives, and their client base has already been developed. Some changes are currently being made to enhance the new product's packaging, as well as formalizing revised training procedures.
The new Accutest-IDenta products are expected to be ready for a final launch in March, but will soon be placed on the Accutest website, www.accutest.net
About Jant Pharmacal:
Jant Pharmacal Corporation was founded in 1986, with a specialization in diagnostics products for the point-of-care markets, including medical, safety/industrial and homeland security segments. Jant Pharmacal Corporation offers one of the largest selections of drug testing products and services in the United States, with an active network of sales representatives and established channels of distribution. Products are marketed under Jant's proprietary labels, including Accutest? and Accustrip?, through national and international distributors, as well as through client private labels.
Jant's products are used in many settings including the workplace, drug treatment centers, hospitals, laboratories, police, probation and parole, and narcotic enforcement agencies. In addition to the United States, Jant Pharmacal Corp also has extensive distribution internationally.
ABOUT IDENTA
Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and most recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. The company has corporate representatives in 20 countries including companies in the U.S., China, France, Indonesia, Poland, Great Britain, Argentina, Ghana, Venezuela etc. Information concerning IDenta's business plan and product line, may be found at www.identa.biz and www.drugsdetector.com.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:
Yaacov Shoham, IDenta Corp., CEO
Tel: +972-52-6554487, +972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com
Dubi,
I agree, this appears to be very significant.
News today,
International Substance Detection Firm IDenta Enters Partnership With Jant Pharmacal - Co-Branded Drug Detection Products To Be Named Accutest-IDenta
JERUSALEM, Israel, February 11 - IDenta Corp. (OTC Pink Sheets: IDTA - News) announced today that it has agreed to enter a strategic partnership with Jant Pharmacal, www.accutest.net, based in Encino California. The agreement is for Jant to have the exclusive distribution of IDenta's STINGER line of professional drug identification products in the United States. The products will bear the new co-brand name of Accutest-IDenta.
"This agreement once again confirms the representations our company has put forth now for many years," stated Yaacov Shoham, CEO of IDenta Corp. "IDenta has a superior drug detection product line which performs with 100% accuracy. Jant Pharmacal is an outstanding company to be associated with, and IDenta is committed to developing a partnership which we believe will help further our reputations as industry leaders. I want to personally thank Mr. Eyal Golan, Manager of Business Development for Jant Pharmacal for his expertise in negotiating this agreement, and for the long hours he has put in to get this far in such a very short time. We expect that the sales of Accutest-IDenta to have an immediate impact on our revenues."
The relationship with Jant Pharmacal has been in development for only a few months with IDenta's products being successfully demonstrated by the company at several major events last months including:
1. 42nd California Narcotic Officers' Association Expo
2. The National Safety Council's Congress & Expo in San Diego
3. COPSWest - Americas Premier Law Enforcement Expo
The events resulted in a very large numbers of leads for IDenta products all over the country, which helped initiate the resulting strategic partnership between the two companies.
Jant Pharmacal currently has over 50 representatives in the United States who are selling the company's drug and explosive detection products to law enforcement and security agencies on the federal, state and local level. A very detailed strategic plan for the introducing the Accutest-IDenta product line to the company's representatives, and their client base has already been developed. Some changes are currently being made to enhance the new product's packaging, as well as formalizing revised training procedures.
The new Accutest-IDenta products are expected to be ready for a final launch in March, but will soon be placed on the Accutest website, www.accutest.net
About Jant Pharmacal:
Jant Pharmacal Corporation was founded in 1986, with a specialization in diagnostics products for the point-of-care markets, including medical, safety/industrial and homeland security segments. Jant Pharmacal Corporation offers one of the largest selections of drug testing products and services in the United States, with an active network of sales representatives and established channels of distribution. Products are marketed under Jant's proprietary labels, including Accutest? and Accustrip?, through national and international distributors, as well as through client private labels.
Jant's products are used in many settings including the workplace, drug treatment centers, hospitals, laboratories, police, probation and parole, and narcotic enforcement agencies. In addition to the United States, Jant Pharmacal Corp also has extensive distribution internationally.
ABOUT IDENTA
Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and most recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. The company has corporate representatives in 20 countries including companies in the U.S., China, France, Indonesia, Poland, Great Britain, Argentina, Ghana, Venezuela etc. Information concerning IDenta's business plan and product line, may be found at www.identa.biz and www.drugsdetector.com.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:
Yaacov Shoham, IDenta Corp., CEO
Tel: +972-52-6554487, +972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com
Rich,
Yeah I'm fine. I'm interested to see what's on the disc. Could be a very valuable marketing tool if APH promotes it enough. Take care, Mike
APH Identa website is up,
Looks like the response was good because the release was run a second time over a major news service.
http://www.aphgroup.us/html/identaconfirm.htm
Authorized and issued shares
remain at 100 million per Nevada Agency and Trust
chucker,
What article?. If you are referring to the website I think it is a new one. Yaacov has been very quiet and I've had no contact with him for about 3 weeks. BTW, most of the trades yesterday at the bid of .004 were buys. Mike
another new one,
http://www.drugformation.com/identaconfirm.html
Institutional holdings,
Go to nasdaq.com and see what's listed for TMMI and what was acquired on 12/31/2006
pamo,
another is TDXG tradex global
TDXG getting some nice volume,
SAN JOSE, COSTA RICA--(MARKET WIRE)--Jan 16, 2007 -- TRADEX Global Financial Services, Inc. (Other OTC:TDXG.PK - News), a holding company that owns TRADEX Inc., a financial services company that provides access to the U.S., Canadian, European and Asian financial markets to foreign investors, announced today that TRADEX Inc. has signed with Interactive Brokers, Inc. based in Greenwich, Connecticut, a new Clearing Agreement which will provide a considerable reduction in its transactional cost.
ADVERTISEMENT
Through this reduction in cost TRADEX Inc., a subsidiary owned by TRADEX Global Financial Services Inc., will be able to lower its ticket prices and offer a more competitive pricing structure with the idea of growing our client base.
"This initial reduction in cost will significantly help us reduce our pricing structure to be able to increase our clientele and benefit the new clients with this reduction in prices," commented TRADEX's CEO Mr. Pozuelo. "Our marketing strategy requires to have a lower clearing cost for us to be able to attract not only more clients but more active clients that can increase our revenue by placing more orders at a lower cost."
About TRADEX, Inc.
TRADEX, Inc., a wholly owned subsidiary of TRADEX Global Financial Services, Inc. (Other OTC:TDXG.PK - News), is a financial services company that is responsible for carrying out all the operations and marketing. TRADEX, Inc. specializes in providing access to the U.S., Canadian and European financial markets for foreign or international investors and corporations, using the highest trading technology and offering various trading platforms and clearing relationships.
Seems to have lost it's momo.
Out at .0005 from .0002. Will watch it but will take some time for revenue to develop.
Thank you for contacting iFinix Corporation. There will always be news and product update on our website www.ifinix.com . If you would like to try our product, please reply to us at your earliest convenience and we would be happy to set you up with a trial base account for a week.
Locating Distributors of Identa Products in Germany and Austria
Sky-Limit, a company operating as the marketing and sales branch for Identa (http://identa.biz) in China and the USA (see box) intends expanding its operations into Germany and Austria. The company’s products include inspection kits for verifying substances suspected of being drugs by diagnosing their identity and existence accurately. Furthermore, during the last quarter, the company made a breakthrough by launching a state of the art kit for identifying and verifying suspected explosive substances.
Sky-Limit, which will be representing the company at the Security Exposition in China during November through the Lotus Company (see box), wants to locate companies in Germany and Austria, which maintain regular close ties with the police, drug enforcement and security forces and inspection units at border crossings. The product’s uniqueness has earned it a reliable and respected reputation amongst global drug enforcement agencies and, thus, it offers a first class business opportunity for a distributor suitable for cooperation.
The casing of the suspected chemical substance identification kit offers inspectors complete safety and is also suitable for civilian applications, for which the company wishes to locate a distributors who have connections and acquaintances at schools and who are familiar with pharmacies for sales to anxious parents
Sky-Limit Setup a Booth at the Safety Fair in Beijing for Identa
Through Lotus International Trade Beijing, Sky-Limit, a company operating as the marketing and sales branch for Identa (http://identa.biz) in China and the USA set up a stall for exhibiting Identa’s products at the Security Exposition, which opened in Beijing on October 28th 2006.
Representatives of the security forces and police from throughout China and approx. 50,000 guests from throughout the world will attend this exposition, considered to be the largest of its kind in the world.
Kits inspecting and accurately diagnosing and verifying substances suspected of being drugs as well as a recently globally launched innovative kit, signifying a breakthrough in identifying and verifying suspect explosive substances will be exhibited at this exposition.
Exhibiting Identa’s products in China is another important step towards exposure in and penetration into the promising Chinese market. Last month, the products underwent successful testing at the substances testing laboratory at the Beijing Police headquarters. The latter intend organizing a symposium for police officers in the various Chinese districts with the purpose of initial exposure for selling them to all the districts in general and particularly to those most affected by the drug trade.
IDenta (http://identa.biz), which was established in Israel, invented the only drug detection tool which detects trace amount of drugs with 100% accuracy.
IDenta’s challenge was the marketing of the professional drug identification kits (Internationally Patented) to a target market of law enforcement agencies, public and private institutions and individuals around the world.
The global need is clear: Police narcotics units around the world frequently experience frustration when they want to arrest a suspect at the scene and begin proceedings, but are forced to release the suspect until the suspicious substance has been identified in the lab.
This is where Skylimit - strategic marketing solutions entered the picture. Our mission is to initiate and effectively execute a marketing and sales process in the target markets where demand and enforcement ability are high.
Initial target markets for the product were set in the United States and Europe.
In a feasibility study conducted by our US partner, testing the product in the US, it became clear that lobbying at the federal level would be required to successfully market the product to federal agencies.
A local law firm, highly experienced in this field, was hired to conduct a process that would lead to the demonstration of the product at federal law enforcement agencies and got extremely positive feedback on the reliability of the identifications provided by the product.
Furthermore, a market survey established that there is a real need for the product in additional sectors: schools, companies wanting to ensure a “drug free” policy and concerned parents.
Up to date, in collaboration with our partners, we screened and hired independent sales companies with presence in Identa’s target markets: Law enforcement authorities, schools, employers and drugstores chains.
Setting up this network took about 2-4 weeks, and doing so guaranteed a quick time to market as well as low costs compared to other alternatives such as establishment of offices and recruitment of local personnel.
From this point on, the sky’s the limit for meeting global targets through the comprehensive packaging of services and relationships we offer.
garagist,
We are valued at about 10 million dollars wheras ACRI is valued at around 100 million and we are marketing products and they only have one product that I know of and it's still being tested. In my opinion we should be valued higher based on future sales.
Bobky,
There are about 400 million available to trade and many of them are held long term. It should move fast when it gets noticed.
TMMI has been slowly going up again.
Ran to 10 cents last summer
bobky,
The two million units are probably what Yaacov knows about now. We really don't know how many new orders will come in over the next year, Not sure of the wholesale prices but think the margins are pretty good. Up to # 17 on quote request board. I expect the news to be released again nationally this morning.
Number 30 on quote request board this morning,
Many people are getting quotes after reading the release from yesterday. The news should be released nationally this morning and may generate more interest. Expansion indicates that business is increasing and it's looks like we are entering a very exciting period for the company.
18 trades between 12:44 and 12:54 totaling about 2 million shares,
Had to fill in many partials.
Bobky was that you picking up some?
bobky,
it will be released tomorrow on PRNewswire
2007 projections on pinksheets,
IDTA -- Identa Corp.
Com ($0.001)
International Drug & Explosives Detection Firm IDenta Initiates Manufacturing Expansion - Forecasts Product Orders From Twenty Countries During 2007
JERUSALEM, Israel, January 3, 2007-- IDenta Corp. (OTC Pink Sheets: IDTA - News) today announced today that it is preparing to make a significant investment to expand and enhance its product assembly line starting in early 2007. The company also released a list of countries, twenty in all, that it expects to be receiving orders from in the coming year.
The announcement said that IDenta expects to invest nearly $500,000 for the manufacturing upgrade, and that orders for IDenta's products are expected to exceed 2 million units during the coming year (2007).
"We are making this investment at this time because we are confident that the demand for our products will increase sizably during the coming year," asserted IDTA CEO Yaacov Shoham. "In the last quarter of 2006 we thoroughly investigated the latest in assembly line technology and have now decided on the right track to proceed." The United States, China, France, Indonesia, Poland, Israel,Singapore, Venezuela, Ghana and Spain are among the countries listed as expected customers during 2007. IDenta forecasts that 35-40% of these orders will be from the United States with the remainder coming from countries around the world. ( the other different countries.)
"Our products, IDenta Stinger and IDenta Confirm [the company's drug detection product lines] and IDenta Alert [the company's explosive detection product line] continue to receive superior test ratings, and we believe that they will more and more be chosen as the preferred products for drug and explosive detection in their respected application categories.
To accommodate the new technology improvements IDenta will be leasing additional space that will nearly double the assembly area. The company expects to add an additional 8 - 10 full-time people to its staff including a chemical engineer to oversee production quality control. The new processing and assembly area will more than double existing production capacity while significantly reducing product unit costs allowing the company to more actively compete with lower priced, less sophisticated products on the market.
"Perhaps the best thing to report to our loyal shareholders is that we expect that the total cost of this expansion project can and will be paid from funds the company's has been reserving for this monumental step forward. We certainly expect that 2007 will be the most important year in our company's history," concluded Shoham.
About IDenta
Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug detection kits and more recently explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. The company has corporate representatives in 20 countries including 15 companies in the U.S., and 4 companies in Great Britain. Information concerning IDenta's business plan and product line, may be found at www.identa.biz and www.drugsdetector.com.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally contact:
Yaacov Shoham, IDenta Corp., CEO
Tel: +972-52-6554487, +972-8-9716874
Fax: +972-8-9716875
fpi@drugsdetector.com
Richie,
Until there is some buying pressure, it's not going anywhere.
Yeah, there is too much uncertainty
as to what is really going on. Hopefully, Yaacov will release some good stuff after the 1st of the year. I think he will address the expansion issue and that will guide us as far as orders that he expects. For Rich, I think the bomb kits are still being tested at Lyon Lab.
Dubi,
I thought Yaacov was going to put out the 2007 projections last week, but he didn't and now he might wait till after the first of the year. I spoke with him yesterday and he still is very bullish about the near term. He didn't elaborate but said he was very busy and things were going very well. Still waiting for some formalities to be finished on the large contract.
Dubi,
For IDTA to have an equal market cap as Acro, we should be trading at 6 cents now. As far as I can see, they only have 1 product and it's not even being marketed yet. We have many products that are currently being marketed and appear to be on the verge many sizeable contracts. Perhaps we will be valued close to them when some of these contracts are announced.
The biggest difference is that Acro is reporting and we aren't, even though their financials show little in the way of income.
Dubi,
In my opinion, our market cap should be 10 times theirs and not the other way around. They have no income according to their 10Q but they are reporting. What we really need is reporting plus results as in contracts. Investors want to see results. You can only have speculation for so long. If ACRO doesn't show results then they too will plummet. I would love to see us with a market cap of 125 million. Mike
Richie,
There was a trade of around 9 million reported after the bell so it didn't count on total. I wasn't around then to see the bid and ask at that time, so I can't tell if they were buys or sells.
Aiming,
I worked for many years for a trucking company and saw packages almost daily that were either leaking or had a foreign substance on them. There is no practical viable way at present to test them. I expect many trucking companies would have a supply at each terminal. Many industries would have a need to stock them.
Aiming,
There would be many instances where the kits would be necessary. For example the trucking industry where there are many instances of leaking parcels or parcels with substances on them. Many, many industries would stock them and use them as necessary. Also the kits are to be used as supplementary kits in the airports to identify the substances. Yaacov probably knows the potential dollar amount of that field.
This site has been active for several months,
http://www.identa.co.za/
Nice new website,
http://www.identadrugtestkits.com/
We should see the 2007 projections soon,
Maybe this week. I don't know what Yaacov is going to reveal, but hope to see estimate for kits sales, update on when financials will be released, update on when a higher listing (OTCQX or on the Emerging Equities List) will take place, update on expansion as mentioned in a former PR, and other things.
Yaacov seems very upbeat about the next year
"I am optimistic actually very optimistic looking for 2007 as a final breakthrough for our products in many markets. It took longer time but we will succeed".
MM's trying to induce selling IMO,
slowly raising bid now to get some trades
News will probably be released on PRN tomorrow.
We'll see if more exposure helps.
MM QUIN (Park Financial)is back,
they are almost always on the ask. Don't know where their shares are coming from.